心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

《2021AHA/ACC心脏瓣膜疾病管理指南解读》——人工瓣膜选择

2022-01-20 华中科技大学同济医学院附属协和医院心脏大血管外科 临床外科杂志

心脏瓣膜疾病人工瓣膜

全球范围内超过4 000万人患有二尖瓣或主动脉瓣疾病,美国每年心脏瓣膜手术量超过180 000例。鉴于全球人口老龄化和瓣膜病流行趋势,伴随经导管主动脉瓣置换(transcatheter aortic

中文标题：

《2021AHA/ACC心脏瓣膜疾病管理指南解读》——人工瓣膜选择

发布机构：

华中科技大学同济医学院附属协和医院心脏大血管外科

发布日期：

2022-01-20

简要介绍：

全球范围内超过4 000万人患有二尖瓣或主动脉瓣疾病,美国每年心脏瓣膜手术量超过180 000例。鉴于全球人口老龄化和瓣膜病流行趋势,伴随经导管主动脉瓣置换(transcatheter aortic valve replacement, TAVR)适应证不断拓宽,预计到 2026 年,全球每年TAVR手术量将超过130 000例。

相关资料下载：
[AttachmentFileName(sort=1, fileName=_2021AHA_ACC心脏瓣膜疾病管理指南解读_人工瓣膜选择_武云龙.pdf)] GetToolGuiderByIdResponse(projectId=1, id=189441c002366afb, title=《2021AHA/ACC心脏瓣膜疾病管理指南解读》——人工瓣膜选择, enTitle=, guiderFrom=临床外科杂志, authorId=0, author=, summary=全球范围内超过4 000万人患有二尖瓣或主动脉瓣疾病,美国每年心脏瓣膜手术量超过180 000例。鉴于全球人口老龄化和瓣膜病流行趋势,伴随经导管主动脉瓣置换(transcatheter aortic , cover=https://img.medsci.cn/2022225/1645798169178_5579292.jpg, journalId=0, articlesId=null, associationId=2464, associationName=华中科技大学同济医学院附属协和医院心脏大血管外科, associationIntro=华中科技大学同济医学院附属协和医院心脏大血管外科, copyright=0, guiderPublishedTime=Thu Jan 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">全球范围内超过4 000万人患有二尖瓣或主动脉瓣疾病,美国每年心脏瓣膜手术量超过180 000例。鉴于全球人口老龄化和瓣膜病流行趋势,伴随经导管主动脉瓣置换(transcatheter aortic valve replacement, TAVR)适应证不断拓宽,预计到 2026 年,全球每年TAVR手术量将超过130 000例。</span></p>, tagList=[TagDto(tagId=6520, tagName=心脏瓣膜疾病), TagDto(tagId=7535, tagName=人工瓣膜)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4017, appHits=137, showAppHits=0, pcHits=661, showPcHits=3879, likes=1, shares=22, comments=3, approvalStatus=1, publishedTime=Sat Feb 26 15:32:00 CST 2022, publishedTimeString=2022-01-20, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 25 22:11:02 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:38:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_2021AHA_ACC心脏瓣膜疾病管理指南解读_人工瓣膜选择_武云龙.pdf)])
_2021AHA_ACC心脏瓣膜疾病管理指南解读_人工瓣膜选择_武云龙.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2194819, encodeId=484921948196d, content=发大水, beContent=null, objectType=guider, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c765450508, createdName=ms1000000737789139, createdTime=Sat Mar 23 08:14:46 CST 2024, time=2024-03-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1202727, encodeId=aea01202e277e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf5e1771308, createdName=ms8547501655805392, createdTime=Tue Mar 15 11:54:19 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197615, encodeId=2dd4119e615a6, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df365576196, createdName=ms3000000182206413, createdTime=Sat Feb 26 22:21:21 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2024-03-23 ms1000000737789139 来自江苏省

    发大水

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194819, encodeId=484921948196d, content=发大水, beContent=null, objectType=guider, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c765450508, createdName=ms1000000737789139, createdTime=Sat Mar 23 08:14:46 CST 2024, time=2024-03-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1202727, encodeId=aea01202e277e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf5e1771308, createdName=ms8547501655805392, createdTime=Tue Mar 15 11:54:19 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197615, encodeId=2dd4119e615a6, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df365576196, createdName=ms3000000182206413, createdTime=Sat Feb 26 22:21:21 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-03-15 ms8547501655805392

    非常实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2194819, encodeId=484921948196d, content=发大水, beContent=null, objectType=guider, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c765450508, createdName=ms1000000737789139, createdTime=Sat Mar 23 08:14:46 CST 2024, time=2024-03-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1202727, encodeId=aea01202e277e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf5e1771308, createdName=ms8547501655805392, createdTime=Tue Mar 15 11:54:19 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197615, encodeId=2dd4119e615a6, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df365576196, createdName=ms3000000182206413, createdTime=Sat Feb 26 22:21:21 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-02-26 ms3000000182206413

    不错

    0